Clinical Trial: CardioSeq: Impact of WGS in Individuals With CVD
Study Status: Completed
Recruit Status: RECRUITING
Condition: Cardiovascular Diseases
Study Type: INTERVENTIONAL
Official Title: CardioSeq: A Prospective, Single-Center, Open-label Study to Evaluate the Impact of Whole Genome Sequencing (WGS) in Individuals With Cardiovascular Disease
Brief Summary:
This is a prospective, single-center, open-label study to investigate the diagnostic efficacy of the TruGenome CVD test and its impact on clinical management compared to usual care in individuals with cardiovascular disease.Diagnostic yield and changes of management (CoM) will be assessed both within the WGS group and compared to a contemporaneous, matched (2:1) usual care (UC) group sourced from EHR records.
Read more